Literature DB >> 25637820

Probing the interaction of cefodizime with human serum albumin using multi-spectroscopic and molecular docking techniques.

Taoying Hu1, Ying Liu2.   

Abstract

To know the interaction of cefodizime (CEF) with human serum albumin (HSA), techniques of different spectroscopies and molecular modeling were used. The inner filter effects were eliminated to get accurate binding parameters. Steady state fluorescence suggested a static type for CEF-HSA interaction, and the complex formation had a high affinity of 10(5) L mol(-1). On the basis of the thermodynamic results and site marker competitive experiments, it was considered that CEF was bound to site I (subdomain IIA) of HSA mainly by hydrogen bonds and van der Waals force. The calculated binding distance (r) indicated that the non-radioactive energy transfer came into being in the interaction between CEF and HSA. Furthermore, molecular modeling was applied to further define that CEF interacted with the Trp214, Lys199, Phe211, Leu238 residues of HSA. In addition, three-dimensional fluorescence and circular dichroism (CD) results showed that the binding of CEF can cause conformational and some microenvironmental changes of HSA. This paper provides reasonable models helping us further understand the transportation and distribution of CEF when it spreads into human blood serum which is of great importance in pharmacology and pharmacodynamics.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cefodizime (CEF); Human serum albumin (HSA); Molecular modeling; Multi-spectroscopic techniques

Mesh:

Substances:

Year:  2015        PMID: 25637820     DOI: 10.1016/j.jpba.2015.01.010

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Insight into the binding interaction of kaempferol-7-O-α-L-rhamnopyranoside with human serum albumin by multiple fluorescence spectroscopy and molecular modeling.

Authors:  Wenting Zhang; Chun Chen; Chunping Zhang; Jingyu Duan; Huankai Yao; Yan Li; Aiguo Meng; Jun Shi
Journal:  Exp Ther Med       Date:  2017-05-04       Impact factor: 2.447

2.  Interaction mechanism of olaparib binding to human serum albumin investigated with NMR relaxation data and computational methods.

Authors:  Yuanming Zhai; Pengchi Deng; Xiaoyan Wang; Chunchun Zhang; Ruixue Gan; Na Gan; Qiaomei Sun; Hui Li
Journal:  RSC Adv       Date:  2018-09-10       Impact factor: 4.036

3.  Investigation of Non-Covalent Interactions of Aflatoxins (B1, B2, G1, G2, and M1) with Serum Albumin.

Authors:  Miklós Poór; Mónika Bálint; Csaba Hetényi; Beatrix Gődér; Sándor Kunsági-Máté; Tamás Kőszegi; Beáta Lemli
Journal:  Toxins (Basel)       Date:  2017-10-25       Impact factor: 4.546

4.  Interaction of the Emerging Mycotoxins Beauvericin, Cyclopiazonic Acid, and Sterigmatocystin with Human Serum Albumin.

Authors:  Eszter Fliszár-Nyúl; Zelma Faisal; Renáta Skaper; Beáta Lemli; Bayarsaikhan Bayartsetseg; Csaba Hetényi; Patrik Gömbös; András Szabó; Miklós Poór
Journal:  Biomolecules       Date:  2022-08-11

5.  Probing the Interactions of Ochratoxin B, Ochratoxin C, Patulin, Deoxynivalenol, and T-2 Toxin with Human Serum Albumin.

Authors:  Zelma Faisal; Virág Vörös; Eszter Fliszár-Nyúl; Beáta Lemli; Sándor Kunsági-Máté; Rita Csepregi; Tamás Kőszegi; Ferenc Zsila; Miklós Poór
Journal:  Toxins (Basel)       Date:  2020-06-13       Impact factor: 4.546

6.  Interactions of zearalanone, α-zearalanol, β-zearalanol, zearalenone-14-sulfate, and zearalenone-14-glucoside with serum albumin.

Authors:  Zelma Faisal; Virág Vörös; Eszter Fliszár-Nyúl; Beáta Lemli; Sándor Kunsági-Máté; Miklós Poór
Journal:  Mycotoxin Res       Date:  2020-08-01       Impact factor: 3.833

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.